Global Molecular Diagnostics Market (2016-2022)

  • ID: 4091248
  • Report
  • Region: Global
  • 422 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

The key driving factors for molecular diagnostics market are high prevalence of infectious diseases and adoption of personalized medicines & companion diagnostics. Additionally, advanced diagnostics technologies and increase in the number of cancer diagnostics are some of the other factors leading the market growth. However, high cost of molecular equipment and delay in the approval of new molecular diagnostics tests could restraint growth of molecular diagnostic market.

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers.

Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Region, market is segmented into North America, Europe, Asia- Pacific and LAMEA (Latin America, Middle East and Africa). North America is expected to dominate the market growth owing to the increase in the number of infectious diseases. Unhealthy lifestyle and infectious diseases is becoming the major concern worldwide. According to the data estimated by Centers for Diseases Control and Prevention (CDC), number of deaths due to cancer estimated was 591,699 and Chronic lower respiratory diseases was 147,101. Additionally, According to the statistics in 2016, approximately 5.1 million people are living with HIV in Asian region. In 2015, there were an estimated 300,000 new infections in the Asia- Pacific. Hence, it could be expected that Asia Pacific and other regions would be contributing in the growth of molecular diagnostics market.

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Molecular Diagnostics Market, by Product & Services
1.4.2 North America Molecular Diagnostics Market, by Technology
1.4.3 North America Molecular Diagnostics Market, by Application
1.4.4 North America Molecular Diagnostics Market, by End User
1.4.5 North America Molecular Diagnostics Market, by Country
1.5 Methodology for the research

2. Executive Summary

3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints

4. North America Molecular Diagnostics Market
4.1 North America Molecular Diagnostics Market by Product & Services
4.1.1 North America Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 North America Molecular Diagnostics Instruments Market by Country
4.1.3 North America Molecular Diagnostics Software & Services Market by Country

5. North America Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 North America Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 North America Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 North America Hybridization Molecular Diagnostics Market by Country
5.1.4 North America DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 North America Microarray Molecular Diagnostics Market by Country
5.1.6 North America Other Technologies Market by Country

6. North America Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 North America Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 North America Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 North America Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 North America Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 North America Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 North America Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 North America Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 North America Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 North America Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 North America Oncology Molecular Diagnostics Market by Country
6.1.4 North America Oncology Molecular Diagnostics Market by Type
6.1.4.1 North America Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 North America Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 North America Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 North America Other Cancers Molecular Diagnostics Market by Country
6.1.5 North America Blood Screening Molecular Diagnostics Market by Country
6.1.6 North America Genetic Tests Molecular Diagnostics Market by Country
6.1.7 North America Microbiology Molecular Diagnostics Market by Country
6.1.8 North America Other Applications Market by Country

7. North America Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 North America Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 North America Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 North America Molecular Diagnostics Market for Other End Users by Country

8. North America Molecular Diagnostics Market by Country
8.1 Introduction
8.2 US Molecular Diagnostics Market
8.2.1 US Molecular Diagnostics Market by Product & Services
8.2.2 US Molecular Diagnostics Market by Technology
8.2.3 US Molecular Diagnostics Market by Application
8.2.3.1 US Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 US Oncology Molecular Diagnostics Market by Type
8.2.4 US Molecular Diagnostics Market by End User
8.3 Canada Molecular Diagnostics Market
8.3.1 Canada Molecular Diagnostics Market by Product & Services
8.3.2 Canada Molecular Diagnostics Market by Technology
8.3.3 Canada Molecular Diagnostics Market by Application
8.3.3.1 Canada Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Canada Oncology Molecular Diagnostics Market by Type
8.3.4 Canada Molecular Diagnostics Market by End User
8.4 Mexico Molecular Diagnostics Market
8.4.1 Mexico Molecular Diagnostics Market by Product & Services
8.4.2 Mexico Molecular Diagnostics Market by Technology
8.4.3 Mexico Molecular Diagnostics Market by Application
8.4.3.1 Mexico Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 Mexico Oncology Molecular Diagnostics Market by Type
8.4.4 Mexico Molecular Diagnostics Market by End User
8.5 Rest of North America Molecular Diagnostics Market
8.5.1 Rest of North America Molecular Diagnostics Market by Product & Services
8.5.2 Rest of North America Molecular Diagnostics Market by Technology
8.5.3 Rest of North America Molecular Diagnostics Market by Application
8.5.3.1 Rest of North America Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Rest of North America Oncology Molecular Diagnostics Market by Type
8.5.4 Rest of North America Molecular Diagnostics Market by End User

9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll